Pregabalin can cause memory problems, though the risk depends on how much you take and how long you use it. The FDA lists both amnesia and “cognitive disorder” as recognized side effects in the official prescribing label for Lyrica. For most people taking standard doses short-term, memory effects tend to be mild and temporary. But the picture gets more concerning with higher doses and longer use.
What the FDA Label Actually Says
The official prescribing information for Lyrica classifies amnesia as an “infrequent” nervous system side effect, meaning it occurs in fewer than 1 in 100 but more than 1 in 1,000 users. Cognitive disorder is listed in the same frequency category. In overdose cases reported after the drug went to market, confusional states and reduced consciousness were among the most commonly reported problems.
“Infrequent” sounds reassuring, but those rates come from controlled clinical trials that typically last weeks to months. The real concern for many users is what happens over years of daily use.
How Pregabalin Affects the Brain
Pregabalin works by binding to a specific part of calcium channels on nerve cells. When it attaches, it reduces the flow of calcium into the nerve terminal, which in turn dials down the release of excitatory brain chemicals. The drug is supposed to target only overexcited neurons, calming them back to a normal state. This is what gives pregabalin its pain-relieving and anti-anxiety effects.
The problem is that the same signaling pathways involved in calming overexcited nerves also play a role in forming and retrieving memories. Reducing excitatory neurotransmitter release can dampen the brain’s ability to encode new information or recall stored information, particularly when the drug’s effects aren’t perfectly limited to the neurons causing pain or anxiety.
Short-Term Effects on Memory
Clinical studies in healthy volunteers paint a somewhat reassuring picture for short-term use. In one trial, people taking 150 mg three times daily for three days showed no significant differences from placebo on vigilance or short-term memory tests. Another study using 150 mg twice daily for 14 days also found no measurable reduction in memory, though the researchers noted the study was small.
The story changes in people already dealing with neurological conditions. In a comparative trial of adults with treatment-resistant epilepsy, pregabalin at 300 mg daily for 14 days caused partly significant impairments in episodic memory for both verbal and visual information. Meanwhile, the comparison drug (levetiracetam) actually improved visual short-term memory. That contrast is worth noting: it suggests pregabalin’s cognitive effects aren’t just a generic side effect of taking any brain-active medication.
A systematic review published in BMC Psychiatry concluded that clinical and preclinical studies “did not confirm” any positive memory effect from pregabalin. The reviewers noted that short-term use in healthy people produces transient central nervous system side effects, but the data was too inconsistent to pool into a single statistical analysis.
Pregabalin vs. Gabapentin
Pregabalin and gabapentin are closely related drugs that work through similar mechanisms, but they don’t appear to be equal when it comes to memory. In a head-to-head animal study, daily pregabalin for 21 consecutive days significantly impaired the ability to distinguish between new and familiar objects, a standard test of recognition memory. Gabapentin given on the same schedule did not produce this effect. The difference between the two drugs was statistically significant.
Combining pregabalin with other medications made things worse. When pregabalin was paired with baclofen (a muscle relaxant), the memory impairment persisted. Gabapentin combined with baclofen also impaired object recognition, even though gabapentin alone did not. If you’re taking pregabalin alongside other medications that affect the central nervous system, the cumulative impact on cognition may be greater than either drug alone.
Long-Term Use and Dementia Risk
The most striking data comes from a large Taiwanese study that tracked users of pregabalin and gabapentin through national health insurance records. The risk of developing dementia increased with higher cumulative doses over the follow-up period. This dose-response relationship, where more drug exposure correlates with more risk, is one of the patterns researchers look for when trying to distinguish a real drug effect from a coincidence.
Surprisingly, the risk was highest in younger users. People under 50 who used these drugs had roughly three times the risk of dementia compared to non-users (a hazard ratio of 3.16). The risk was still elevated but lower in older groups: about 1.6 times higher for people in their 50s, 1.5 times for those in their 60s, and 1.3 times for people 70 and older. This pattern is counterintuitive, since older adults are generally more vulnerable to cognitive side effects. It may reflect the fact that dementia in a young person is rare enough that any drug-related increase stands out sharply in statistical terms.
The association held across nearly all subgroups the researchers examined, with two exceptions: people with depression and those with a history of head injury did not show a statistically significant increase. The reason for these exceptions isn’t entirely clear, but it may relate to the already-elevated baseline dementia risk in those groups muddying the signal.
This is observational data, not a randomized trial, so it can’t prove pregabalin directly causes dementia. People prescribed these drugs often have chronic pain, epilepsy, or anxiety, conditions that themselves may carry some cognitive risk. But the dose-response pattern and the consistency across age groups make the findings difficult to dismiss.
What the Cognitive Effects Feel Like
If you’re experiencing memory issues while taking pregabalin, they typically show up as difficulty recalling recent events, trouble finding words, or a general mental fogginess that makes it harder to concentrate. Some people describe it as feeling like their thinking has slowed down, or that information they just learned seems to slip away more easily than it should. These effects overlap heavily with what people casually call “brain fog.”
The sedation that pregabalin commonly causes can compound the problem. When you’re drowsy or mentally sluggish, encoding new memories becomes harder, and it can be difficult to tell whether the drug is directly impairing your memory circuits or simply making you too drowsy to pay full attention in the first place. Both mechanisms likely play a role.
Factors That Increase Your Risk
Several factors appear to raise the likelihood of experiencing memory problems on pregabalin:
- Higher cumulative doses. The Taiwanese database study found a clear dose-response pattern, with greater total drug exposure linked to greater dementia risk.
- Longer duration of use. Short-term studies in healthy volunteers generally show minimal effects, while long-term observational data raises more serious concerns.
- Combination with other CNS-active drugs. Taking pregabalin alongside opioids, benzodiazepines, muscle relaxants, or other sedating medications compounds cognitive side effects.
- Higher daily doses. Studies testing 300 mg per day found memory impairments that weren’t seen at 150 mg per day, though individual responses vary.
If you’ve noticed cognitive changes since starting pregabalin or after a dose increase, the timing itself is useful information to bring up with whoever prescribes your medication. For many people, the effects are reversible when the dose is reduced or the drug is discontinued, though tapering should always be done gradually to avoid withdrawal symptoms.